Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86401-86450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05316493
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
PHASE2/PHASE3Recruiting
172 participants
Started: Jun 13, 2022 · Completed: Feb 28, 2027
3 conditions1 sponsor1 location
NCT05425953
Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype
N/ARecruiting
320 participants
Started: Jun 13, 2022 · Completed: May 1, 2025
6 conditions2 sponsors1 location
NCT05301101
High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis
NARecruiting
120 participants
Started: Jun 13, 2022 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT05483985
Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer
NAActive, not recruiting
440 participants
Started: Jun 13, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor7 locations
NCT05370430
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
PHASE1Recruiting
36 participants
Started: Jun 13, 2022 · Completed: Jun 13, 2028
1 condition2 sponsors5 locations
NCT04785989
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
N/ARecruiting
16 participants
Started: Jun 13, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05204407
Luteolin for the Treatment of People With Schizophrenia
NARecruiting
60 participants
Started: Jun 13, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors2 locations
NCT04142177
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
NARecruiting
2,529 participants
Started: Jun 13, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor19 locations
NCT05468437
Telenutrition for Individuals With SCI
NARecruiting
96 participants
Started: Jun 13, 2022 · Completed: Sep 30, 2026
3 conditions3 sponsors1 location
NCT05706220
Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
N/AEnrolling by invitation
120 participants
Started: Jun 13, 2022 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT06363071
APA and PAS Training for Gait Initiation in Parkinson's Disease
NARecruiting
100 participants
Started: Jun 13, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06285110
HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen
N/ARecruiting
2,600 participants
Started: Jun 13, 2022 · Completed: Aug 31, 2025
1 condition5 sponsors22 locations
NCT05386134
Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders
N/ARecruiting
200 participants
Started: Jun 13, 2022 · Completed: Jun 13, 2033
2 conditions1 sponsor1 location
NCT05369130
Investigate and Predict Aortic & Thoracic Surgery Persistenet Postsurgical Pain
N/ARecruiting
60 participants
Started: Jun 12, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05415527
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management
NARecruiting
25 participants
Started: Jun 11, 2022 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05216965
A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors
PHASE1/PHASE2Recruiting
208 participants
Started: Jun 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05003947
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD
PHASE1Recruiting
15 participants
Started: Jun 11, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT05096195
PRevEnting FracturEs in REnal Disease - 1
PHASE4Active, not recruiting
60 participants
Started: Jun 11, 2022 · Completed: Dec 31, 2025
4 conditions5 sponsors6 locations
NCT06822959
Pharmacogenetics, Therapeutic Drug Monitoring (TDM) and Active Pharmacovigilance as Innovative Tools Aimed at the Optimisation/ Appropriateness of Drug Therapy
N/ARecruiting
450 participants
Started: Jun 10, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors2 locations
NCT05335434
Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation
NARecruiting
20 participants
Started: Jun 10, 2022 · Completed: Sep 19, 2025
4 conditions2 sponsors1 location
NCT05276024
Evaluation of the IFuse Bedrock Technique in Association with Posterior Lumbosacral Fusion with Iliac Fixation.
N/ARecruiting
50 participants
Started: Jun 10, 2022 · Completed: Apr 1, 2026
4 conditions2 sponsors2 locations
NCT05374447
Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy
NARecruiting
55 participants
Started: Jun 10, 2022 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT05153811
The Less is More Study
NARecruiting
120 participants
Started: Jun 10, 2022 · Completed: Sep 1, 2026
1 condition5 sponsors2 locations
NCT05379738
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy
NARecruiting
75 participants
Started: Jun 10, 2022 · Completed: Apr 10, 2028
1 condition1 sponsor1 location
NCT05352919
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
PHASE3Enrolling by invitation
864 participants
Started: Jun 10, 2022 · Completed: Mar 29, 2030
1 condition1 sponsor157 locations
NCT04672733
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
N/ARecruiting
100 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor27 locations
NCT05339841
Italian Digital Primary Cardiovascular Prevention Study
NAActive, not recruiting
27,520 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2029
1 condition14 sponsors32 locations
NCT05347134
SKB264 Injection Vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
PHASE3Active, not recruiting
254 participants
Started: Jun 10, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor2 locations
NCT06897098
Regeneration of Knee and Ankle Cartilage From Autologous Cartilage Mini-grafts (From the Patient's Own Cells)
PHASE1Active, not recruiting
11 participants
Started: Jun 10, 2022 · Completed: Apr 2, 2025
1 condition1 sponsor3 locations
NCT06822816
Video/Image Library of Endoscopy Procedures for the Development of AI-empowered Endoscopy Quality Reporting and Educational Modules
N/ARecruiting
10,000 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT04941404
A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)
PHASE1/PHASE2Active, not recruiting
13 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor4 locations
NCT05211232
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
450 participants
Started: Jun 10, 2022 · Completed: May 30, 2028
1 condition5 sponsors4 locations
NCT05329766
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
PHASE2Active, not recruiting
332 participants
Started: Jun 10, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors49 locations
NCT05521958
Gene Expression in Lower Extremity Acute Traumatic Compartment Syndrome
NAEnrolling by invitation
80 participants
Started: Jun 10, 2022 · Completed: Jun 30, 2028
2 conditions1 sponsor1 location
NCT04989647
Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
PHASE3Recruiting
514 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT04981509
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
PHASE2Recruiting
65 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2027
6 conditions1 sponsor13 locations
NCT05119140
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis
PHASE1/PHASE2Active, not recruiting
3 participants
Started: Jun 10, 2022 · Completed: May 31, 2025
1 condition2 sponsors2 locations
NCT05339438
Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients
NARecruiting
30 participants
Started: Jun 10, 2022 · Completed: Jun 9, 2027
2 conditions1 sponsor1 location
NCT05339555
IUD Self-Removal Study
NARecruiting
30 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05341141
Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy
NARecruiting
102 participants
Started: Jun 10, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT06214962
Comprehensive Dementia Management : From Translational Medicine to Innovative Care
N/ARecruiting
652 participants
Started: Jun 10, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05412589
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC
PHASE2Recruiting
35 participants
Started: Jun 10, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05022901
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma
PHASE3Active, not recruiting
30 participants
Started: Jun 10, 2022 · Completed: Mar 1, 2024
2 conditions1 sponsor5 locations
NCT05406622
MOTIV BTK Randomized Controlled Trial
NARecruiting
292 participants
Started: Jun 10, 2022 · Completed: Mar 31, 2029
1 condition1 sponsor4 locations
NCT05242419
A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery
NARecruiting
40 participants
Started: Jun 10, 2022 · Completed: Dec 30, 2025
4 conditions2 sponsors1 location
NCT05419076
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
PHASE2Recruiting
62 participants
Started: Jun 10, 2022 · Completed: Jun 10, 2026
6 conditions1 sponsor8 locations
NCT05386901
The Effects of Individualized Lung-protective Ventilation With Lung Dynamic Compliance-guided Positive End-expiratory Pressure(PEEP) Titration on Postoperative Pulmonary Complications of Pediatric Video-assisted Thoracoscopic Surgery
NAEnrolling by invitation
60 participants
Started: Jun 10, 2022 · Completed: Oct 1, 2024
2 conditions1 sponsor1 location
NCT05098210
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
PHASE1Recruiting
25 participants
Started: Jun 9, 2022 · Completed: Nov 1, 2027
25 conditions2 sponsors1 location
NCT05245500
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
PHASE1Recruiting
320 participants
Started: Jun 9, 2022 · Completed: Apr 30, 2026
6 conditions1 sponsor24 locations
NCT05429697
Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer
PHASE2/PHASE3Recruiting
128 participants
Started: Jun 9, 2022 · Completed: Jun 8, 2026
1 condition1 sponsor3 locations